Martin Gleize

All filings by Martin Gleize on record concern Roche Bobois SA, in the capacity of senior executive. We count 40 filings; the first trade dates from 3 February 2021 and the latest from 27 July 2026.

The open-market side counts 3 purchases for €265k alongside 33 sales for €1.7M. Netting one side against the other leaves €1.4M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants. Since January 2026: no purchases and 8 sales on the market.

In size, the median ticket on the buying side is €49k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -16.4%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 27 August 2026, reports a share grant in Roche Bobois SA. The last insider purchase was made public on 8 December 2021, 1,774 days ago. Filings reach the AMF feed a median of 4 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from AMF. Past trades are no guide to future returns.